U.S. Managed Care Market (Medicare, Medicaid, and Private Health Insurance): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
The US health expenditure is forecasted to reach US$6.41 trillion in 2028, experiencing growth at a CAGR of 5.62% during the period spanning from 2024 to 2028. The national health expenditure by source of funds can be segmented as follows: Managed care, Out of pocket, Investments and Others. In 2023, the dominant share was held by managed care segment. This was being followed by out of pocket, investments and others.
The US managed care market is forecasted to reach US$4.37 trillion in 2028, experiencing growth at a CAGR of 6.09% during the period spanning from 2024 to 2028. Growth in the US managed care market is supported by factors such as rise in global healthcare expenditure, escalating urban population, rising geriatric population, increasing prevalence of cancer cases, favorable government initiatives, and growing adoption of healthcare insurance. However, the market growth is expected to be restrained by lack of knowledge and privacy.
The US managed care market by payer can be segmented into the following segments: Private Health Insurance, Medicare and Medicaid. In 2023, the dominant share of the US managed care market was held by Private Health Insurance, followed by Medicare and Medicaid. The faster growth in the net cost of health insurance is a primary reason for the acceleration in spending growth for private health insurance, Medicaid, and Medicare.
During Covid-19, there is a greater need for sophisticated healthcare, which raises healthcare expenditures. However, most people find it difficult to spend that much money on their healthcare needs, and hence the managed care industry is expanding during the time of COVID peak.
Scope of the report:
The report provides a comprehensive analysis of the US managed care market with potential impact of COVID-19.
The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
The competitive landscape of the market, along with the company profiles of leading players (Anthem, CVS, Cigna, Centene, United Health Group, Molina Healthcare) are also presented in detail.
Key Target Audience:
Insurance Agencies
Managed Care Providers
Healthcare Providers
End Users (Businesses/Consumers)
Investment Banks
Government Bodies & Regulating Authorities
1. Market Overview
1.1 Managed Care
1.1.1 Introduction
1.1.2 History
1.2 Features of Managed Care
1.3 Types of Managed Care Plans
1.4 Advantages and Disadvantages of Managed Care
Table 1: Advantages and Disadvantages of Managed Care
1.5 Segments of Managed Care
1.6 Services of Managed Care
Table 2: Services of Managed Care
2. Impact of COVID-19
2.1 Impact of COVID-19 on Healthcare Industry
2.2 Impact of COVID-19 on Managed Care Market
2.3 Prevalence of COVID-19
Table 3: Rising Coronavirus Cases in the US (Feb 2020- Feb 2022)
2.4 Impact on Healthcare Spending
Table 4: Y/Y Growth Rates in National Health Spending (Jan 2020-Oct 2020)
2.5 Y/Y Growth in Medicaid Enrollment
Table 5: Y/Y Growth in Medicaid Enrollment (Nov 2020-Nov 2021)
2.6 Technological Advancements
3. The US Market Analysis
3.1 The US Health Expenditure
Table 6: The US Health Expenditure (2019-2023)
3.2 The US Health Expenditure Forecast
Table 7: The US Health Expenditure Forecast (2024-2028)
3.3 The US Health Expenditure by Source of Funds
Table 8: The US Health Expenditure by Source Of Funds (2023)
3.4 The US Managed Care Market by Value
Table 9: The US Managed Care Market by Value (2019-2023)
3.5 The US Managed Care Market Forecast by Value
Table 10: The US Managed Care Market Forecast by Value (2024-2028)
3.6 The US Managed Care Market by Payer
Table 11: The US Managed Care Market by Payer (2023)
3.6.1 The US Private Health Insurance (PHI) Market by Value
Table 12: The US Private Health Insurance (PHI) Market by Value (2019-2023)
3.6.2 The US Private Health Insurance (PHI) Market Forecast by Value
Table 13: The US Private Health Insurance (PHI) Market Forecast by Value (2024-2028)
3.6.3 The US Private Health Insurance (PHI) by Per Enrollee Spending Forecast
Table 14: The US Private Health Insurance (PHI) by Per Enrollee Spending Forecast (2019-2028)
3.6.4 The US Private Health Insurance (PHI) by Enrollment Forecast
Table 15: The US Private Health Insurance (PHI) by Enrollment Forecast (2019-2028)
3.6.5 The US Medicare Market by Value
Table 16: The US Medicare Market by Value (2019-2023)
3.6.6 The US Medicare Market Forecast by Value
Table 17: The US Medicare Market Forecast by Value (2024-2028)
3.6.7 The US Medicare by Per Enrollee Spending Forecast
Table 18: The US Medicare by Per Enrollee Spending Forecast (2019-2028)
3.6.8 The US Medicare by Enrollment Forecast
Table 19: The US Medicare by Enrollment Forecast (2019-2028)
3.6.9 The US Medicaid Market by Value
Table 20: The US Medicaid Market by Value (2019-2023)
3.6.10 The US Medicaid Market Forecast by Value
Table 21: The US Medicaid Market Forecast by Value (2024-2028)
3.6.11 The US Medicaid by Per Enrollee Spending Forecast
Table 22: The US Medicaid by Per Enrollee Spending Forecast (2024-2028)
3.6.12 The US Medicaid by Enrollment Forecast
Table 23: The US Medicaid by Enrollment Forecast (2019-2028)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rise in Healthcare Expenditure
Table 24: The US Health Expenditures as a Percent of Gross Domestic Product (2017-2023)
4.1.2 Escalating Urban Population
Table 25: The US Urban Population (2018-2023)
4.1.3 Rising Geriatric Population
Table 26: The US Geriatric Population (2011-2040)
4.1.4 Increasing Prevalence of Cancer Cases
Table 27: The US Estimated Number of New Cases of Cancer by Gender (2023)